Search results
...Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares -...
Benzinga· 9 hours agoOn Wednesday, Ark Invest, led by the influential investor Cathie Wood, executed notable trades...
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
InvestorPlace· 7 days agoModerna (NASDAQ:MRNA) stock is up more than 20% in just the past five trading sessions as investors foresee strong growth opportunities for the biotechnology ...
Moderna and this solar name are among the most overbought stocks after a record-setting week
CNBC· 6 days agoIt may be time for investors to trim positions in overbought names after the stock market reached...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 16 hours agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 4 days agoThe vaccine maker's shares are down by 43% since then. Moderna isn't resting on its laurels, though....
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In...
Benzinga· 4 days agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
Futures slip as rate-cut uncertainty persists; data on tap
Colorado Springs Gazette· 2 hours agoRising bond yields typically reflect expectations for higher interest rates, which in turn means...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 6 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Stock market today: Wall Street drifts in quiet trading after returning from a 3-day weekend - WTOP ...
WTOP Washington· 2 days agoWall Street is listless on Tuesday, coming back from a three-day weekend, and is drifting near its...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 7 days agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...